Project title: NHS National Framework for Transition products (Nilotinib and Ticagrelor) commencing 1st September 2025
Offer reference number: CM/TNS/24/5721
Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months.
Potential periods of call-offs under the framework agreement:
CM/TNS/24/5721/01 – Nilotinib and Ticagrelor
Lot 1 DCE/DNW/DNE: 01/09/2025 to 31/01/2027 (17 months)
Lot 2 DLN/DLS/DSW: 01/09/2025 to 31/01/2027 (17 months)
Published By:…

You must be logged in to view the rest of this content, click here to login

Don't have an account, click to sign up for our 14-day free trial.